Screener
Denali Therapeutics Inc. DNLI Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
FAQ
- What is Denali Therapeutics Inc.'s common stock shares issued?
- Denali Therapeutics Inc. (DNLI) reported common stock shares issued of 159.8M in Q2 2026.
- How has Denali Therapeutics Inc.'s common stock shares issued changed year-over-year?
- Denali Therapeutics Inc.'s common stock shares issued increased by 9.7% year-over-year, from 145.7M to 159.8M.
- What is the long-term trend for Denali Therapeutics Inc.'s common stock shares issued?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s common stock shares issued has grown at a 5.3% compound annual growth rate (CAGR), from 120.5M to 156.2M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.
Ask your AI about Denali Therapeutics Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude